|
US3475466A
(en)
*
|
1965-08-30 |
1969-10-28 |
Schering Corp |
Novel 17,21-diesters of 16alpha-methyl-9alpha,11beta-dichloro-1,4- pregnadienes
|
|
US3422193A
(en)
*
|
1966-08-11 |
1969-01-14 |
Schering Corp |
17-mono esters of corticoids
|
|
IT1061787B
(it)
*
|
1967-03-01 |
1983-04-30 |
Vismara Francesco Spa |
Miglioramenti relativi alla preparazione di 17 benzoato di betametazone
|
|
GB1281689A
(en)
*
|
1968-10-14 |
1972-07-12 |
Glaxo Lab Ltd |
Steroid 21-phosphates
|
|
US3694471A
(en)
*
|
1970-06-08 |
1972-09-26 |
Warner Lambert Pharmaceutical |
17-valerate ester of 6{60 ,9{60 -difluorohydrocortisone, its compositions and use as an anti-inflammatory agent
|
|
DK135267A
(cg-RX-API-DMAC10.html)
*
|
1971-02-25 |
|
|
|
|
US3789121A
(en)
*
|
1971-11-26 |
1974-01-29 |
Warner Lambert Co |
17{60 ,21-orthobutyrates of 6{60 , 9{60 -difluoro-hydrocortisone and 6{60 , 9{60 -difluoroprednisolone, compositions containing same and the use thereof as anti-inflammatory agents
|
|
GB1429184A
(en)
*
|
1972-04-20 |
1976-03-24 |
Allen & Hanburys Ltd |
Physically anti-inflammatory steroids for use in aerosols
|
|
US4044126A
(en)
*
|
1972-04-20 |
1977-08-23 |
Allen & Hanburys Limited |
Steroidal aerosol compositions and process for the preparation thereof
|
|
SE418294B
(sv)
*
|
1974-03-27 |
1981-05-18 |
Plurichemie Anstalt |
Sett att framstella en 16alfa- eller 16beta-9alfa-klor eller -fluorsteroidester
|
|
US4018918A
(en)
*
|
1975-05-20 |
1977-04-19 |
The Upjohn Company |
Topical clindamycin preparations
|
|
DE2645104C2
(de)
*
|
1976-10-04 |
1986-04-24 |
Schering AG, 1000 Berlin und 4709 Bergkamen |
11β-Hydroxy-1,4,8-pregnatrien-3,20-dion-Derivate und Verfahren zu ihrer Herstellung
|
|
US4070462A
(en)
*
|
1976-10-26 |
1978-01-24 |
Schering Corporation |
Steroid ointment
|
|
JPS6040439B2
(ja)
*
|
1978-03-29 |
1985-09-11 |
大正製薬株式会社 |
ヒドロコルチゾン誘導体
|
|
EP0029924B1
(en)
*
|
1979-11-16 |
1984-08-15 |
STEROSYNT Ltd. |
6-alpha-fluoro-16-methyl-prednisolone-17,21 diesters and pharmaceutical compositions containing them
|
|
US4350690A
(en)
*
|
1980-10-27 |
1982-09-21 |
Cressington Investments Ltd. |
Steroid composition
|
|
US4346086A
(en)
*
|
1981-06-09 |
1982-08-24 |
Beiersdorf Aktiengesellschaft |
Corticosteroid-containing cream
|
|
IL66432A0
(en)
*
|
1981-08-04 |
1982-12-31 |
Plurichemie Anstalt |
Process for the preparation of steroidal esters
|
|
DE3133081A1
(de)
*
|
1981-08-18 |
1983-03-10 |
Schering Ag, 1000 Berlin Und 4619 Bergkamen |
Neue 6(alpha)-methylprednisolon-derivate, ihre herstellung und verwendung
|
|
FR2515041A1
(fr)
*
|
1981-10-26 |
1983-04-29 |
Besins Jean |
Medicament a base de progesterone pour le traitement des affections mammaires
|
|
EP0095894A3
(en)
*
|
1982-05-31 |
1985-01-02 |
Ohta Seiyaku Kabushiki Kaisha. |
6 alpha-methylprednisolone derivatives
|
|
DE3227312A1
(de)
*
|
1982-07-19 |
1984-01-19 |
Schering AG, 1000 Berlin und 4709 Bergkamen |
Neue 6,16-dimethylkortikoide, ihre herstellung und verwendung
|
|
DE3243482A1
(de)
*
|
1982-11-22 |
1984-05-24 |
Schering AG, 1000 Berlin und 4709 Bergkamen |
Neue 6(alpha)-methylkortikoide, ihre herstellung und verwendung
|
|
US4489070A
(en)
*
|
1983-05-13 |
1984-12-18 |
Schering Corporation |
Betamethasone dipropionate cream
|
|
US4482539A
(en)
*
|
1983-05-13 |
1984-11-13 |
Schering Corporation |
Betamethasone dipropionate cream
|
|
DE3400188A1
(de)
*
|
1984-01-02 |
1985-07-11 |
Schering AG, Berlin und Bergkamen, 1000 Berlin |
Neue 6(alpha),16(alpha)-dimethylkortikoide
|
|
PT78973A
(en)
*
|
1984-07-25 |
1984-08-01 |
Joao Emerico Villax |
New preparation process of the 9alpha-fluoro 17,21-acylates or hidroxilades in 17 and 21 chloro-corticosteroid
|
|
US6536427B2
(en)
|
1990-03-02 |
2003-03-25 |
Glaxo Group Limited |
Inhalation device
|
|
MY105368A
(en)
*
|
1990-03-02 |
1994-09-30 |
Glaxo Group Ltd |
Inhalation device.
|
|
HU213221B
(en)
|
1990-03-02 |
1997-03-28 |
Glaxo Group Ltd |
Inhalation device and medicine packet for device
|
|
GB0019172D0
(en)
*
|
2000-08-05 |
2000-09-27 |
Glaxo Group Ltd |
Novel compounds
|
|
US6759398B2
(en)
*
|
2000-08-05 |
2004-07-06 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative
|
|
US6858596B2
(en)
*
|
2000-08-05 |
2005-02-22 |
Smithkline Beecham Corporation |
Formulation containing anti-inflammatory androstane derivative
|
|
US6777399B2
(en)
*
|
2000-08-05 |
2004-08-17 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative compositions
|
|
WO2002012265A1
(en)
*
|
2000-08-05 |
2002-02-14 |
Glaxo Group Limited |
6.ALPHA., 9.ALPHA.-DIFLUORO-17.ALPHA.-`(2-FURANYLCARBOXYL) OXY!-11.BETA.-HYDROXY-16.ALPHA.-METHYL-3-OXO-ANDROST-1,4,-DIENE-17-CARBOTHIOIC ACID S-FLUOROMETHYL ESTER AS AN ANTI-INFLAMMATORY AGENT
|
|
US7291608B2
(en)
*
|
2001-04-30 |
2007-11-06 |
Glaxo Group Limited |
Anti-inflammatory 17.β.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.α
|
|
JP2005500290A
(ja)
*
|
2001-06-12 |
2005-01-06 |
グラクソ グループ リミテッド |
抗炎症性の、１７β−カルボチオアートアンドロスタン誘導体である１７α複素環エステル
|
|
WO2003048181A1
(en)
*
|
2001-12-01 |
2003-06-12 |
Glaxo Group Limited |
17.alpha. -cyclic esters of 16-methylpregnan-3,20-dione as anti-inflammatory agents
|
|
US20050175545A1
(en)
*
|
2002-02-04 |
2005-08-11 |
Keith Biggadike |
Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
|
|
GB0202635D0
(en)
*
|
2002-02-05 |
2002-03-20 |
Glaxo Wellcome Mfg Pte Ltd |
Formulation containing novel anti-inflammatory androstane derivative
|
|
GB2389530B
(en)
*
|
2002-06-14 |
2007-01-10 |
Cipla Ltd |
Pharmaceutical compositions
|
|
EP1663999A2
(en)
*
|
2003-08-29 |
2006-06-07 |
Ranbaxy Laboratories, Ltd. |
Inhibitors of phosphodiesterase type-iv
|
|
US20070259874A1
(en)
*
|
2003-11-26 |
2007-11-08 |
Palle Venkata P |
Phosphodiesterase Inhibitors
|
|
US20080009535A1
(en)
*
|
2004-08-30 |
2008-01-10 |
Sarala Balachandran |
Inhibitors of phosphodiesterase type-IV
|
|
GB0507165D0
(en)
*
|
2005-04-08 |
2005-05-18 |
Glaxo Group Ltd |
Novel crystalline pharmaceutical product
|
|
US7915286B2
(en)
|
2005-09-16 |
2011-03-29 |
Ranbaxy Laboratories Limited |
Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
|
|
US20090221664A1
(en)
|
2005-10-19 |
2009-09-03 |
Abhijit Ray |
Pharmaceutical compositions of muscarinic receptor antagonists
|
|
CA2626628A1
(en)
*
|
2005-10-19 |
2007-04-26 |
Ranbaxy Laboratories Limited |
Compositions of phosphodiesterase type iv inhibitors
|
|
GB0615108D0
(en)
*
|
2006-07-28 |
2006-09-06 |
Glaxo Group Ltd |
Novel formulations
|
|
EP2066661A2
(en)
*
|
2006-09-22 |
2009-06-10 |
Ranbaxy Laboratories Limited |
Phosphodiesterase inhibitors
|
|
CN101616901A
(zh)
*
|
2006-09-22 |
2009-12-30 |
兰贝克赛实验室有限公司 |
Iv型磷酸二酯酶的抑制剂
|
|
EP1958947A1
(en)
|
2007-02-15 |
2008-08-20 |
Ranbaxy Laboratories Limited |
Inhibitors of phosphodiesterase type 4
|
|
EP2124943A1
(en)
*
|
2007-03-14 |
2009-12-02 |
Ranbaxy Laboratories Limited |
Pyrazolo [3, 4-b]pyridine derivatives as phosphodiesterase inhibitors
|
|
PL2124944T3
(pl)
|
2007-03-14 |
2012-08-31 |
Sun Pharmaceutical Ind Ltd |
Pochodne pirazolo[3,4-b]pirydyny jako inhibitory fosfodiesterazy
|
|
US8796248B2
(en)
|
2007-10-05 |
2014-08-05 |
Nektar Therapeutics |
Oligomer-corticosteroid conjugates
|
|
EP2111861A1
(en)
|
2008-04-21 |
2009-10-28 |
Ranbaxy Laboratories Limited |
Compositions of phosphodiesterase type IV inhibitors
|
|
CN112358522B
(zh)
*
|
2020-05-18 |
2021-11-16 |
河南利华制药有限公司 |
一种倍他米松二丙酸酯的精制方法及倍他米松二丙酸酯
|
|
CN111944002A
(zh)
*
|
2020-07-29 |
2020-11-17 |
河南利华制药有限公司 |
一种倍氯米松二丙酸酯中间体及制备方法
|
|
CN116023425B
(zh)
*
|
2023-03-28 |
2023-06-20 |
南京师范大学 |
曲安西龙衍生物及其医药用途
|